KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Taxes (2016 - 2021)

BeOne Medicines (ONC) has disclosed Change in Taxes for 6 consecutive years, with $7.1 million as the latest value for Q1 2021.

  • On a quarterly basis, Change in Taxes rose 17.58% to $7.1 million in Q1 2021 year-over-year; TTM through Mar 2021 was $3.4 million, a 73.27% decrease, with the full-year FY2020 number at $2.3 million, down 69.35% from a year prior.
  • Change in Taxes was $7.1 million for Q1 2021 at BeOne Medicines, down from $14.6 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $14.6 million in Q4 2020 to a low of -$9.3 million in Q3 2020.
  • A 5-year average of $1.2 million and a median of $969000.0 in 2019 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: soared 5251.52% in 2017, then tumbled 1730.22% in 2018.
  • BeOne Medicines' Change in Taxes stood at $6.3 million in 2017, then plummeted by 32.55% to $4.3 million in 2018, then grew by 3.32% to $4.4 million in 2019, then surged by 232.14% to $14.6 million in 2020, then tumbled by 51.0% to $7.1 million in 2021.
  • Per Business Quant, the three most recent readings for ONC's Change in Taxes are $7.1 million (Q1 2021), $14.6 million (Q4 2020), and -$9.3 million (Q3 2020).